TAVI - Procedural strategy

Session comprising selected EuroPCR 2026 late-breaking trials submissions

Anchorperson: P. Maccarthy

Spokesperson: K. Hayashida

Summary

This session focuses on procedural strategies for TAVI, examining the influence of coronary artery disease severity on PCI decision-making, revascularisation approaches in high-bleeding risk patients, the role of CT imaging and implant depth in procedural planning, and comparative evaluation of pre-dilatation versus direct valve implantation in bicuspid aortic valves.

Presentations available when logged in:

The impact of coronary artery disease severity on PCI decision-making in patients undergoing TAVI
Coronary revascularisation strategies in high-bleeding risk patients undergoing TAVI
CT quality and implant depth in TAVI: membranous septum length in the optimise PRO study
Pre-dilatation vs. direct valve implant for TAVI with balloon-expandable valve in Sievert Type 1 bicuspid aortic valve

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

TAVI - Procedural strategy

Session comprising selected EuroPCR 2026 late-breaking trials submissions

Log in or create account for free